We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$45.5B
AUM Growth
-$3.53B
Cap. Flow
-$2.66B
Cap. Flow %
-5.84%
Top 10 Hldgs %
15.18%
Holding
3,042
New
156
Increased
1,044
Reduced
1,302
Closed
139

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$84.6M
2
AMZN icon
Amazon
AMZN
+$77.8M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$72.8M
4
BKNG icon
Booking.com
BKNG
+$59.4M
5
AAPL icon
Apple
AAPL
+$58.5M

Top Sells

Rank Stock Value
1
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$804M
2
WFC.PRL icon
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
+$728M
3
SWT
Stanley Black & Decker, Inc.
SWT
+$139M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$97.5M
5
NEE.PRP
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
+$87.5M

Sector Composition

Rank Sector Weight
1 Technology 19.29%
2 Financials 13.84%
3 Healthcare 13.73%
4 Consumer Discretionary 9.83%
5 Real Estate 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERU icon
2726
Veru
VERU
$47.6M
$15K ﹤0.01%
134
-95
-41% -$13.7K
PRDS
2727
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$15K ﹤0.01%
+8,536
New +$25.5K
ALBO
2728
DELISTED
Albireo Pharma Inc
ALBO
$15K ﹤0.01%
776
– –
AEIS icon
2729
Advanced Energy
AEIS
$13.1B
$14K ﹤0.01%
193
– –
KAI icon
2730
Kadant
KAI
$4B
$14K ﹤0.01%
85
– –
KALV
2731
DELISTED
KalVista Pharmaceuticals
KALV
$14K ﹤0.01%
+1,004
New +$14K
LCII icon
2732
LCI Industries
LCII
$2.61B
$14K ﹤0.01%
138
– –
BCML icon
2733
BayCom
BCML
$341M
$13K ﹤0.01%
811
-2,432
-75% -$47K
BVN icon
2734
Compañía de Minas Buenaventura
BVN
$8.84B
$13K ﹤0.01%
1,972
-26,796
-93% -$159K
CHMG icon
2735
Chemung Financial Corp
CHMG
$396M
$13K ﹤0.01%
327
-62
-16% -$2.79K
FENG
2736
Phoenix New Media
FENG
$18.1M
$13K ﹤0.01%
2,705
-3,568
-57% -$17.6K
RAPT
2737
DELISTED
RAPT Therapeutics
RAPT
$13K ﹤0.01%
+68
New +$12.9K
WSBC icon
2738
WesBanco
WSBC
$4.05B
$13K ﹤0.01%
417
– –
FDMT icon
2739
4D Molecular Therapeutics
FDMT
$600M
$12K ﹤0.01%
+1,569
New +$14.2K
KOD icon
2740
Kodiak Sciences
KOD
$2.64B
$12K ﹤0.01%
+1,572
New +$15.3K
SPRO icon
2741
Spero Therapeutics
SPRO
$71.2M
$12K ﹤0.01%
6,400
– –
AFMD
2742
DELISTED
Affimed
AFMD
$11K ﹤0.01%
566
– –
CYH icon
2743
Community Health Systems
CYH
$400M
$11K ﹤0.01%
5,200
-53,023
-91% -$176K
FATE icon
2744
Fate Therapeutics
FATE
$319M
$11K ﹤0.01%
529
– –
GLUE icon
2745
Monte Rosa Therapeutics
GLUE
$1.34B
$11K ﹤0.01%
+1,431
New +$13.1K
NRIX icon
2746
Nurix Therapeutics
NRIX
$2.69B
$11K ﹤0.01%
+879
New +$13.9K
YMAB
2747
DELISTED
Y-mAbs Therapeutics
YMAB
$11K ﹤0.01%
+816
New +$13.5K
VBIV
2748
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$11K ﹤0.01%
539
-147
-21% -$3.96K
KNTE
2749
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$11K ﹤0.01%
+955
New +$12.5K
CDTX
2750
DELISTED
Cidara Therapeutics
CDTX
$10K ﹤0.01%
855
– –
108 109
110
111 112

Similar funds

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Russell Investments Group's Q3 2022 Portfolio in Review

As of Q3 2022, Russell Investments Group held 3,042 positions worth $45.5B, down 7.2% from $49B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Russell Investments Group withdrew a net $2.66B in Q3 2022, closing 139 positions and reducing 1,302 holdings. Its most notable exit was Healthcare Realty Trust Incorporated, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Russell Investments Group opened a new position in Haleon worth $19.4M.

  • Russell Investments Group's largest Q3 2022 buy was Haleon: 3,190,513 shares worth $19.4M.
  • Russell Investments Group added most to SLB Ltd in Q3 2022, an estimated $84.6M increase.
  • Russell Investments Group's biggest Q3 2022 reduction was Bank of America Series L, cutting an estimated $804M.
  • Russell Investments Group fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $31.7M.
  • Russell Investments Group's ten largest holdings make up 15% of its $45.5B portfolio in Q3 2022.
  • Russell Investments Group opened 156 new positions and closed 139 in Q3 2022.
  • Russell Investments Group's portfolio value fell 7.2% quarter-over-quarter to $45.5B.

Based on Russell Investments Group's 13F filing for Q3 2022, filed 4 Nov 2022.